Andreessen Horowitz September 20, 2024
Vineeta Agarwala

Cells are a remarkable unit of life. They carry the ability to reproduce, to grow into tissues and organs, to sense and respond to their environments, to store and use energy, and to manufacture and secrete products of many kinds throughout the body. They have evolved enormous complexity, well beyond our capacity for de novo design. It is not surprising, then, that in many human diseases, when our cells are depleted or aged or not functioning, cellular medicines—delivering new cells back to the body—might offer the most logical and the most comprehensive form of therapeutic intervention available.

Scalable cellular medicines: the holy grail

Cell therapy is indeed a holy grail that has captivated the field of regenerative medicine for decades....

Today's Sponsors

Venturous
Got healthcare questions? Just ask Transcarent

Today's Sponsor

Venturous

 
Topics: Biotechnology, Investments, Pharma / Biotech, Trends
Will Trump Drug Tariffs Help Or Hurt The U.S.?
Johnson & Johnson Discontinues Pivotal Depression Drug Trial Due to Lack of Efficacy
First-in-Class Brain Cancer Drug Strikes a Chord With Jazz Pharma to the Tune of a $935M M&A Deal
Medicare Coverage Of Medical Technologies In A New Era
A Bright Future for AI in Pharma

Share This Article